{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"105-482-721-786-501","frontPageModel":{"patentViewModel":{"ref":{"entityRefType":"PATENT","entityRefId":"105-482-721-786-501"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":8902,"type":"PATENT","title":"University of Tokyo Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":20983,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8217,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search applicants and owners = \"Univ Tokyo\", \"Univ Tokyo NOT metropolitan\", \"Tokyo Univ\",\"University of Tokyo NOT metropolitan\", \"Tokyo Univ\".
Select more for logical variants
Add to collection
Total patent: 13934
Search applicants and owners = \"Univ Tokyo\", \"Univ Tokyo NOT metropolitan\", \"Tokyo Univ\",\"University of Tokyo NOT metropolitan\", \"Tokyo Univ\".
Select more for logical variants
Add to collection
Total patent: 13934
(a) determining the expression level of the stanniocalcin 2 (STC2) gene in a subject-derived prostate tissue wherein said expression level is determined by detecting a translation product of the STC2 gene;\n
(b) comparing the subject-derived expression level determined in step (a) with a normal control level obtained from normal prostate epithelial cells; and\n
(c) correlating an increase of said subject-derived expression level as compared to the normal control level to a diagnosis of prostate cancer."],"number":1,"annotation":false,"title":false,"claim":true},{"lines":["The method of claim 1, wherein said prostate cancer is castration-resistant prostate cancer or aggressive prostate cancer."],"number":2,"annotation":false,"title":false,"claim":true},{"lines":["The method of claim 2, wherein said aggressive prostate cancer is prostate cancer with Gleason score 8 to 10."],"number":3,"annotation":false,"title":false,"claim":true}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}